We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

188 hedge funds and large institutions have $370M invested in SANGAMO THERAPEUTICS INC in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 74 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more call options, than puts

Call options by funds: $2.56M | Put options by funds: $1.54M

61% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 46

6.98% more ownership

Funds ownership: 54.16% → 61.14% (+7%)

4% less funds holding

Funds holding: 195 → 188 (-7)

14% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 21

19% less capital invested

Capital invested by funds: $458M → $370M (-$87.4M)

Holders
188
Holders Change
-7
Holders Change %
-3.59%
% of All Funds
3.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
74
Reduced
46
Closed
21
Calls
$2.56M
Puts
$1.54M
Net Calls
+$1.02M
Net Calls Change
-$672K

Top Buyers

Rank Fund Capital Flow
1
RCMU
Rokos Capital Management (UK)
United Kingdom
+$8.86M
2
WA
Wasatch Advisors
Utah
+$7.85M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.01M
4
CC
Casdin Capital
New York
+$4.32M
5
BlackRock
BlackRock
New York
+$3.25M

Top Sellers

Rank Fund Capital Flow
1
GLA
Great Lakes Advisors
Illinois
-$3.04M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$1.53M
3
PAM
Panagora Asset Management
Massachusetts
-$1.16M
4
UBS Group
UBS Group
Switzerland
-$1.14M
5
CI Investments Inc
CI Investments Inc
Ontario, Canada
-$875K
Name Holding Trade Value Shares
Change 		Change in
Stake
WA
1
Wasatch Advisors
Utah
$51.3M +$7.85M +1,815,322 +17%
BlackRock
2
BlackRock
New York
$51.2M +$3.25M +751,070 +6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$47.7M +$6.01M +1,389,297 +14%
State Street
4
State Street
Massachusetts
$32M -$155K -35,856 -0.5%
CS
5
Credit Suisse
Switzerland
$15.7M +$13.3K +3,065 +0.1%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$12.8M +$1.05M +242,734 +9%
RCMU
7
Rokos Capital Management (UK)
United Kingdom
$12.5M +$8.86M +2,048,547 +210%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$8.98M +$331K +76,642 +4%
JP Morgan Chase
9
JP Morgan Chase
New York
$6.25M +$38.4K +8,890 +0.6%
Goldman Sachs
10
Goldman Sachs
New York
$6M +$1.23M +284,772 +24%
Renaissance Technologies
11
Renaissance Technologies
New York
$5.96M +$2.93M +676,400 +89%
Morgan Stanley
12
Morgan Stanley
New York
$5.86M +$2.4M +555,560 +65%
Millennium Management
13
Millennium Management
New York
$4.99M +$2.23M +515,625 +75%
Northern Trust
14
Northern Trust
Illinois
$4.83M -$144K -33,407 -3%
HighTower Advisors
15
HighTower Advisors
Illinois
$4.79M +$467K +108,016 +10%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$4.79M +$1.74M +401,463 +53%
N
17
Nuveen
North Carolina
$4.5M -$623K -144,010 -12%
CC
18
Casdin Capital
New York
$4.14M +$4.32M +1,000,000 New
Hudson Bay Capital Management
19
Hudson Bay Capital Management
Connecticut
$3.73M +$519K +120,000 +15%
Charles Schwab
20
Charles Schwab
California
$3.63M -$26.1K -6,030 -0.7%
Assenagon Asset Management
21
Assenagon Asset Management
Luxembourg
$3.61M – – –
LOAMS
22
Lombard Odier Asset Management (Switzerland)
Switzerland
$3.22M -$354K -81,933 -10%
Federated Hermes
23
Federated Hermes
Pennsylvania
$3.02M -$1.53M -354,854 -33%
Two Sigma Investments
24
Two Sigma Investments
New York
$3.02M +$1.59M +368,438 +102%
Manulife (Manufacturers Life Insurance)
25
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.95M +$2.5K +577 +0.1%
1
2 3 4 5

SGMO Hedge Fund Activity: Q2 2022 in Review

188 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2022, worth a combined $370M — down 19% from $458M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of SGMO and 18 opened new positions — a net loss of 3 holders — while 46 trimmed existing stakes and 74 added.

The largest buyer was Rokos Capital Management (UK), adding an estimated $8.86M. The largest seller was Great Lakes Advisors, exiting entirely with an estimated $3.04M sold.

  • 188 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2022, down from 195 in Q1 2022.
  • Funds reported $370M of SANGAMO THERAPEUTICS INC stock for Q2 2022, down 19% quarter-over-quarter.
  • 18 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2022 and 21 closed out, a net change of -3 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2022 was Rokos Capital Management (UK), an estimated $8.86M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2022 was Great Lakes Advisors, an estimated $3.04M sold.

Based on aggregated 13F filings for Q2 2022.